Company: NKLR
Filing Date: 2025-09-16
Form Type: 424B3
Source: 0001213900-25-087981
Chunk: 207

Company: Terra Innovatum Global N.V.
Filing Date: 2025-09-16
Form: 424B3
Chunk 207
---
                          |     | Uses        
 Assuming    
 No          
 Redemptions 
 Into Cash   |       |     | Assuming    
 50%         
 Redemptions 
 Into Cash   |       |     | Assuming    
 Maximum     
 Redemptions 
 Into Cash   |       |
|:---------------------------------------|:----|:------------|------:|:----|:------------|------:|:----|:------------|------:|
| Terra Innovatum Global Quotaholders(1) |     | $           | 475.0 |     | $           | 475.0 |     | $           | 475.0 |
| Cash to balance sheet                  |     |             | 219.7 |     |             | 100.4 |     |             |  16.2 |
| Transaction costs(2)                   |     |             |  19.0 |     |             |  19.0 |     |             |  19.0 |
| Total Uses                             |     | $           | 713.7 |     | $           | 594.4 |     | $           | 510.2 |

____________ (1)This amount is the aggregate value of PubCo Ordinary Shares issued to legacy Terra Innovatum Global Quotaholders pursuant to the Business Combination Agreement. The value represents the number of PubCo Ordinary Shares issued to Terra Innovatum Global Quotaholders in the amount of 47,500,000, at a per share value of $10.00. (2) This amount includes the assumed payment on the Closing Date of the following transaction related costs, (i) payment of a deferred underwriting fee in the amount of $9.2million, (ii) $7.1million of advisory, legal and other professional fees incurred by Terra Innovatum, (iii) $2.1million of advisory and other professional fees incurred by GSR III, (iv) a $300.0

81 thousand premium for a directors’ and officers’ tail insurance policy covering directors and officers coming from GSR III, and (v) a $300.0 thousand premium for a directors’ and officers’ insurance policy covering directors and officers coming from Terra Innovatum. Accounting Treatment of the Business Combination In connection with the Terra Pre -ClosingRestructuring, each issued and outstanding quota of New TopCo will be converted into PubCo Ordinary Shares at the Common Conversion Ratio. Subsequent to the Terra Pre -ClosingRestructuring, GSR III